App-Quantinova.ai

A risk score predicting ICU outcome in solid cancer patients.

Ting-Hui Wu - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Multilevel correlates of in-hospital mortality among patients with malignant solid tumors in the United States.

Kahee A. Mohammed - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Management of febrile neutropenia in the observation unit of a cancer hospital.

Adam Klotz - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Association between patient perception of oncology clinical trial participation and survival: N0392 (Alliance).

Jennifer Le-Rademacher - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Outcomes of ICU admission of patients with progressive metastatic gastrointestinal (GI) cancer.

Andrew S. Epstein - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Feasibility of a high-throughput molecular tumor board (MTB) to provide clinical practice guidance following comprehensive molecular profiling (CMP).

Ari M. Vanderwalde - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Tamsulosin Hydrochloride

Natural history of heparin-induced thrombocytopenia (HIT) in the cancer population.

Myra Pearl Wong - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Heparin

The benefit of modern cancer therapy for older patients.

Amandeep Mahal - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Overall survival (OS) of acute promyelocytic leukemia (APL) treated in academic (AC) versus non academic (NAC) centers.

Smith Giri - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Comparison of trends and outcomes of hematopoietic stem cell transplant in geriatric ( 65 years) and non-geriatric (50-64 years) patients with cancer.

Achuta Kumar Guddati - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Solid malignancies

N/A

Evaluation of hematology/oncology patient and physician expectations for integrative oncology at a tertiary care center.

Damien Mikael Hansra - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Methadone hydrochloride

Fertility preservation: A novel method to improve fertility discussion and documentation.

Nalini Hasija - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Barriers to patients understanding of prognosis in advanced cancer.

Jason Palopoli - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Methadone hydrochloride

Engaging pediatric patients and caregivers in an oral chemotherapy safety assessment.

Jessica A. Zerillo - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Assessing solid tumor response with and without RECIST.

Aileen Deng - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Development of a benchmark tool for Comprehensive Cancer Centers: Results from a pilot exercise.

Anke Wind - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Methadone hydrochloride

Using patients and oncologists voices to shape a communication skills trial.

Nina A. Bickell - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Piloting a generic cancer consumer quality index for cancer patients in European countries.

Anke Wind - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The impact of an adolescent and young adult (AYA) consultation service on addressing patient needs at Princess Margaret Cancer Center.

Laura Mitchell - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

A Quality Improvement project to decrease overuse of vancomycin in an inpatient Hematology/Oncology service.

Shebli Atrash - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

vancomycin capsule

Filters

41730 Abstracts